Vetamer Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Vetamer Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,891	Closed	-$957K	–	69
2023 Q3	$957K	Sell	1,891 -1,543	-45%	-$822K	1.33%	28
2023 Q2	$1.79M	Buy	3,434 +158	+5%	+$85.3K	2.37%	13
2023 Q1	$1.89M	Sell	3,276 -51	-2%	-$28.7K	2.6%	13
2022 Q4	$1.83M	Buy	+3,327	New	+$1.76M	2.5%	13

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vetamer Capital Management's TMO Position: Q4 2023 in Review

Vetamer Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 1,891 shares — an estimated $957K sold.

Vetamer Capital Management first reported a position in TMO in Q4 2022 and held it in 4 quarters. The position peaked at $1.89M in Q1 2023. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Vetamer Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Vetamer Capital Management sold 1,891 Thermo Fisher Scientific shares in Q4 2023, an estimated $957K.
Vetamer Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 4 quarters.
Vetamer Capital Management's Thermo Fisher Scientific position peaked at $1.89M in Q1 2023.
2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Vetamer Capital Management's 13F filing for Q4 2023.